Regencell Bioscience (RGC) has had the highest return since January 31, 2022 by a large-cap US stock, returning 2,484.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 2,484.3% |
Celestica (CLS) | 2,332.82% |
Ast Spacemobile (ASTS) | 1,451.49% |
Palantir Technologies (PLTR) | 1,214.49% |
Carpenter Technology (CRS) | 1,153.69% |
Credo Technology (CRDO) | 1,151.92% |
Comfort Systems USA (FIX) | 1,073.73% |
Fortress Transp & Infra Inv (FTAI) | 989.16% |
Madrigal Pharmaceuticals (MDGL) | 903.16% |
Applovin (APP) | 900.19% |
Robinhood Markets (HOOD) | 811.54% |
Rocket Lab USA (RKLB) | 808.32% |
Vertiv (VRT) | 778.88% |
YPF Sociedad Anonima (YPF) | 764.05% |
Summit Therapeutics (SMMT) | 758.82% |
BridgeBio Pharma (BBIO) | 758.78% |
Constellation Energy (CEG) | 723.42% |
Insmed (INSM) | 723.05% |
Vistra Energy (VST) | 722.67% |
NVIDIA (NVDA) | 716.22% |
Oklo (OKLO) | 702.06% |
Super Micro Computer (SMCI) | 675.75% |
TechnipFMC (FTI) | 649.64% |
Bloom Energy (BE) | 615.14% |
Reddit (RDDT) | 611.44% |
Large-cap stocks are treated as having a market cap of $10B+.
